Manufacturer
NOVUGEN PHARMA SDN. BHD.(MALAYSIA)
Registraction Number
MAL24116033AZ
Content:
Savagen 97mg/103mg Film-Coated Tablets contain Sacubitril 97.2 mg and Valsartan 102.8 mg as active ingredients. Each tablet is designed for oral use only.
Indications:
NOVUGEN PHARMA SDN. BHD.(MALAYSIA)
Registraction Number
MAL24116033AZ
Content:
Savagen 97mg/103mg Film-Coated Tablets contain Sacubitril 97.2 mg and Valsartan 102.8 mg as active ingredients. Each tablet is designed for oral use only.
Indications:
- Heart failure: Savagen is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure.
- Hypertension: Savagen is also indicated for the treatment of essential hypertension.
- Dosage: The recommended starting dose for heart failure is one tablet of 49mg/51mg twice daily, which can be doubled to one tablet of 97mg/103mg twice daily after 2-4 weeks, as tolerated by the patient.
- Administration: Take the tablet orally with water, swallowing it whole. Do not crush or chew the tablet.
- Timing: Take Savagen on an empty stomach, either one hour before or two hours after food.
- Precautions: Inform your doctor if you have kidney disease, liver disease, or any other health conditions. Avoid taking Savagen with certain medications that may interact with it.
- Storage: Store below 30°C, away from moisture and heat.
Inquiry - Savagen 97mg/103mg Film Coated Tablets